In Apparent Shift, Venter Says Celera Won t Map Proteome | GenomeWeb

NEW YORK, April 5 - Several months ago, after announcing the completion of the sequencing of the human genome, Craig Venter, president of Celera, stated that his next feat would be to tackle the human proteome.

But this week Venter appeared to be announcing a new focus for his industrial-sized proteomics effort, as he downplayed the importance of the proteome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.